Total Payments
$46,146
2024 Payments
$16,953
Companies
36
Transactions
155
Medicare Patients
4,685
Medicare Billing
$3.3M
Payment Breakdown by Category
Other$32,705 (70.9%)
Travel$6,754 (14.6%)
Food & Beverage$6,686 (14.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,690 | 13 | 70.8% |
| Travel and Lodging | $6,754 | 11 | 14.6% |
| Food and Beverage | $6,686 | 130 | 14.5% |
| Entertainment | $15.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | $37,093 | 28 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $1,914 | 4 | $0 (2024) |
| Cardinal Health 414, LLC | $1,277 | 4 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $797.98 | 6 | $0 (2023) |
| Elekta, Inc. | $589.33 | 7 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $532.14 | 13 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $493.93 | 7 | $0 (2024) |
| Boston Scientific Corporation | $445.39 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $416.66 | 19 | $0 (2024) |
| Myovant Sciences Inc. | $286.93 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,953 | 47 | PROGENICS PHARMACEUTICALS, INC. ($13,844) |
| 2023 | $18,859 | 34 | Progenics Pharmaceuticals, Inc. ($17,859) |
| 2022 | $6,427 | 28 | Progenics Pharmaceuticals, Inc. ($5,390) |
| 2021 | $368.07 | 5 | Janssen Scientific Affairs, LLC ($142.00) |
| 2020 | $395.58 | 6 | Elekta, Inc. ($221.30) |
| 2019 | $644.55 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($123.69) |
| 2018 | $634.50 | 11 | Augmenix, Inc. ($206.86) |
| 2017 | $1,864 | 14 | Cardinal Health 414, LLC ($1,277) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Diagnostic Imaging | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: Oncology | ||||||
| 11/14/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Immunotherapy | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Space OAR_URO | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $90.44 | General |
| Category: Oncology | ||||||
| 10/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 10/04/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,640.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/04/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $142.92 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 09/21/2024 | Siemens Medical Solutions USA, Inc. | — | Travel and Lodging | In-kind items and services | $299.70 | General |
| 09/19/2024 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $127.44 | General |
| 09/16/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $27.57 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,640.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $722.79 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/05/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $149.92 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/23/2024 | Siemens Medical Solutions USA, Inc. | Varian Ethos Treatment Planning (Device) | Travel and Lodging | In-kind items and services | $788.70 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $163.28 | General |
| 08/06/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Space OAR_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,223 | 2,361 | $3.3M | $904,712 |
| 2022 | 19 | 1,147 | 1,894 | $2.9M | $740,928 |
| 2021 | 21 | 1,089 | 1,932 | $2.9M | $737,232 |
| 2020 | 22 | 1,226 | 2,199 | $3.3M | $881,302 |
Total Patients
4,685
Total Services
8,386
Medicare Billing
$3.3M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2023 | 140 | 237 | $1.4M | $448,157 | 31.7% |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Office | 2023 | 46 | 47 | $418,990 | $121,668 | 29.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 60 | 62 | $307,861 | $83,853 | 27.2% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 69 | 279 | $391,686 | $72,850 | 18.6% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 66 | 66 | $96,260 | $32,177 | 33.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 62 | 589 | $103,578 | $29,087 | 28.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 79 | 236 | $144,370 | $21,160 | 14.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 60 | 60 | $65,675 | $20,814 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 136 | $34,011 | $11,500 | 33.8% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 82 | 82 | $31,902 | $10,239 | 32.1% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 30 | 57 | $40,416 | $8,366 | 20.7% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 82 | 90 | $38,376 | $7,791 | 20.3% |
| 77470 | Special radiation treatment | Office | 2023 | 72 | 72 | $96,540 | $7,616 | 7.9% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 94 | 122 | $39,462 | $7,428 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $21,654 | $6,841 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 109 | $22,078 | $6,567 | 29.7% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 14 | 34 | $16,754 | $5,810 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $9,550 | $2,678 | 28.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $396.00 | $109.20 | 27.6% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2022 | 112 | 199 | $1.2M | $380,831 | 31.4% |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Office | 2022 | 34 | 34 | $309,671 | $86,640 | 28.0% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 97 | 226 | $531,912 | $60,838 | 11.4% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 41 | 41 | $191,168 | $54,856 | 28.7% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2022 | 63 | 63 | $87,204 | $31,489 | 36.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 131 | 243 | $144,585 | $22,247 | 15.4% |
About Dr. Peter Fried, MD
Dr. Peter Fried, MD is a Radiation Oncology healthcare provider based in Fairfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851384671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Fried, MD has received a total of $46,146 in payments from pharmaceutical and medical device companies, with $16,953 received in 2024. These payments were reported across 155 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,690).
As a Medicare-enrolled provider, Fried has provided services to 4,685 Medicare beneficiaries, totaling 8,386 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology, Radiation Oncology
- Location Fairfield, OH
- Active Since 08/26/2005
- Last Updated 07/01/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1851384671
Products in Payments
- PYLARIFY (Drug) $37,093
- Varian Ethos Treatment Planning (Device) $788.70
- PROVENGE (Drug) $493.93
- ERLEADA (Drug) $477.62
- SpaceOAR VUE System - 10mL (Device) $403.88
- Xofigo (Drug) $341.18
- ORGOVYX (Drug) $334.63
- PLUVICTO (Drug) $295.92
- SpaceOAR (Device) $266.62
- Erleada (Drug) $254.02
- THERASPHERE - BIO (Device) $212.87
- ELEKTA MEDICAL LINEAR ACCELERATOR (Device) $202.22
- Nubeqa (Drug) $190.96
- Icon (Device) $135.79
- Axonics r-SNM System (Device) $127.44
- Xtandi (Drug) $124.13
- LYNPARZA (Biological) $123.84
- ZYTIGA (Drug) $123.42
- Rubraca (Drug) $120.70
- LYNPARZA (Drug) $120.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.